<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36560907</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1442-200X</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Pediatrics international : official journal of the Japan Pediatric Society</Title><ISOAbbreviation>Pediatr Int</ISOAbbreviation></Journal><ArticleTitle>Post coronavirus disease 2019 condition in children at a children's hospital in Japan.</ArticleTitle><Pagination><StartPage>e15458</StartPage><MedlinePgn>e15458</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e15458</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/ped.15458</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute coronavirus disease 2019 (COVID-19) is associated with chronic symptoms. These have been termed the "post COVID-19 condition." The data on this condition in children are still limited. We therefore aimed to elucidate the characteristics of this post COVID-19 condition.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Children referred to a long COVID-19 clinic were included at Tokyo Metropolitan Children's Medical Center between October 2021 and July 2022. Children with another diagnosis and those who failed to meet criteria for post COVID-19 condition were excluded. Demographic and clinical data were collected retrospectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 33 referrals, nine were excluded, and 24 fulfilled the criteria for post COVID-19 condition. The median age and percentage of girls were 12.5 (IQR: 11-13) years and 29.2%, respectively. All the patients had mild, acute COVID-19. Dysgeusia and brain fog was observed more frequently during the Delta and Omicron variant periods, respectively. School absenteeism &gt;4&#x2009;weeks was observed in 41.6% of the patients. Common symptoms included malaise, headache, dysgeusia, and dysosmia. The median duration of post COVID-19 condition was 4.5 (IQR: 2.8-5.2) months. Pain management and counseling using the pacing approach were the most commonly offered treatments. Symptom resolution and improvement was observed in 29.2% and 54.2% of the patients, respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">One third of the patients referred for long COVID did not fit the definition of the post COVID-19 condition. After a median follow up of 4.5&#x2009;months, the majority of the cases resolved or improved.</AbstractText><CopyrightInformation>&#xa9; 2023 Japan Pediatric Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Horikoshi</LastName><ForeName>Yuho</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-5875-1024</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibata</LastName><ForeName>Meiwa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funakoshi</LastName><ForeName>Hanako</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7680-4510</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baba</LastName><ForeName>Shintaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Otorhinolaryngology, Tokyo Metropolitan Children's Medical Center, Fuchu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyama</LastName><ForeName>Sahoko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Neurology, Tokyo Metropolitan Children's Medical Center, Fuchu, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Pediatr Int</MedlineTA><NlmUniqueID>100886002</NlmUniqueID><ISSNLinking>1328-8067</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004408" MajorTopicYN="N">Dysgeusia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">child</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post COVID-19 condition</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>2</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36560907</ArticleId><ArticleId IdType="pmc">PMC9880635</ArticleId><ArticleId IdType="doi">10.1111/ped.15458</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Izquierdo-Pujol J, Moron-Lopez S, Dalmau J, Gonzalez-Aumatell A, Carreras-Abad C, Mendez M, et al. Post COVID-19 condition in children and adolescents: an emerging problem. Front Pediatr. 2022;10:894204.</Citation></Reference><Reference><Citation>Asadi-Pooya AA, Nemati H, Shahisavandi M, Akbari A, Emami A, Lotfi M, et al. Long COVID in children and adolescents. World J Pediatr. 2021;17:495-9.</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220-32.</Citation></Reference><Reference><Citation>Trapani G, Verlato G, Bertino E, Maiocco G, Vesentini R, Spadavecchia A, et al. Long COVID-19 in children: an Italian cohort study. Ital J Pediatr. 2022;48:83.</Citation></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. The challenge of studying long COVID: an updated review. Pediatr Infect Dis J. 2022;41:424-6.</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102-7.</Citation></Reference><Reference><Citation>Pellegrino R, Chiappini E, Licari A, Galli L, Marseglia GL. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J Pediatr. 2022;181:1-15.</Citation></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Dis J. 2021;40:e482-7.</Citation></Reference><Reference><Citation>WHO. Coronavirus disease (COVID-19): post COVID-19 condition. [Accessed 2022 August 17]. Available from https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition</Citation></Reference><Reference><Citation>CDC. Long COVID or Post-COVID Conditions. [Accessed 2022 November 2]. Available from https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html</Citation></Reference><Reference><Citation>Bureau of Social Welfare and Public Health, Tokyo. Variant strain (Japanese). [Accessed 2022 August 17]. Available from https://www.fukushihoken.metro.tokyo.lg.jp/iryo/kansen/corona_portal/henikabu/screening.html</Citation></Reference><Reference><Citation>Goldman RD. Long COVID in children. Can Fam Physician. 2022;68:263-5.</Citation></Reference><Reference><Citation>Prime Minister's Office. Vaccination rates for each age. [Accessed 2022 November 2]. Available from https://www.kantei.go.jp/jp/content/nenreikaikyubetsu-vaccination_data.pdf</Citation></Reference><Reference><Citation>Japan pediatric society. View point on COVID-19 vaccinations among 5-17&#x2009;years old children (Japanese). [Accessed 2022 August 17]. Available from. http://www.jpeds.or.jp/modules/activity/index.php?content_id=451</Citation></Reference><Reference><Citation>Iio K, Hagiwara Y, Saito O, Ishida Y, Horikoshi Y. Seizure in children with severe acute respiratory syndrome coronavirus 2 omicron variant infection. Pediatr Int. 2022;64:e15255.</Citation></Reference><Reference><Citation>Japanese society of intensive care medicine. Brief report on moderate and severe cases of pediatric COVID-19 (Japanese). [Accessed 2022 August 17]. Available from https://www.jsicm.org/news/upload/220725JSICM_jscts.pdf</Citation></Reference><Reference><Citation>UK Health Security Agency. The effectiveness of vaccination against long COVID. [Accessed 2022 August 17]. Available from https://ukhsa.koha-ptfs.co.uk/cgi-bin/koha/opac-retrieve-file.pl?id=fe4f10cd3cd509fe045ad4f72ae0dfff</Citation></Reference><Reference><Citation>Siberry VGR, Rowe PC. Pediatric long COVID and Myalgic encephalomyelitis/chronic fatigue syndrome: overlaps and opportunities. Pediatr Infect Dis J. 2022;41:e139-41.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE). Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. [Accessed 2022 August 17]. Available from https://www.nice.org.uk/guidance/ng206</Citation></Reference><Reference><Citation>Stephenson T, Pinto Pereira SM, Shafran R, de Stavola BL, Rojas N, McOwat K, et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health. 2022;6:230-9.</Citation></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature. 2022;604:697-707.</Citation></Reference><Reference><Citation>Morand A, Campion JY, Lepine A, Bosdure E, Luciani L, Cammilleri S, et al. Similar patterns of [(18)F]-FDG brain PET hypometabolism in paediatric and adult patients with long COVID: a paediatric case series. Eur J Nucl Med Mol Imaging. 2022;49:913-20.</Citation></Reference><Reference><Citation>Tana C, Bentivegna E, Cho SJ, Harriott AM, Garc&#xed;a-Azor&#xed;n D, Labastida-Ramirez A, et al. Long COVID headache. J Headache Pain. 2022;23:93.</Citation></Reference><Reference><Citation>Simmons AC, Bonner A, Giel A, Pezzano A, Rothner AD. Probable new daily persistent headache after COVID-19 in children and adolescents. Pediatr Neurol. 2022;132:1-3.</Citation></Reference><Reference><Citation>Dono F, Consoli S, Evangelista G, D'Apolito M, Russo M, Carrarini C, et al. New daily persistent headache after SARS-CoV-2 infection: a report of two cases. Neurol Sci. 2021;42:3965-8.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>